Strategies for Safe Living Following Solid Organ Transplantation

American Society of Transplantation

Overview
Preventing direct contact infections
Preventing respiratory infections
Water safety and cryptosporidium
Food safety
Animal contact and pet safety
Safe sexual practices
Travel safety
Citation
Strength of Recommendations
References

Overview

The risk of infection following solid organ transplantation is determined by the recipient’s net state of immunosuppression, epidemiologic exposures and the consequences of the invasive procedures to which the recipient has been subjected (1-4).  Transplant recipients are at risk for developing infection with endogenous organisms that are reactivated during periods of excess immunosuppression.  They may also develop opportunistic infections with exogenously-acquired organisms if exposed to a high inoculum or particularly virulent microbes, even during periods of minimal or maintenance immunosuppression(1-4).  Various measures can be taken to reduce high-risk epidemiologic exposures in the hospital and in the community, and transplant recipients should be counseled in ways to minimize the risk of infection.  Furthermore, strategies for safe living must be carefully woven with the transplant recipient’s attempts to regain normal function and return to normal life.  
Solid organ transplant recipients are at greatest risk of infection during the first six months after transplantation and at any time that their immunosuppression is augmented for episodes of rejection.  In addition to the dose and duration of immunosuppressive therapy, the type of immunosuppressive used is important in determining the risk of infection.  For example, corticosteroids increase the risk for disseminating infection with fungi such as Aspergillus, Coccidioides, and Candida, whereas, anti-lymphocyte therapies (OKT3, antithymocyte globulin) are associated with cytomegalovirus (CMV) reactivation.

There are no “hard data” or controlled studies regarding safe living practices following solid organ transplantation.  Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients (5) and in persons infected with human immunodeficiency virus (6), drafted by various working groups that include members from the Centers for Disease Control, Infectious Diseases Society of America, United States Public Health Service, and American Society of Blood and Marrow Transplantation, were used to prepare this document.  Thus, the recommendations that follow are based on anecdotal clinical experience, available knowledge of the mode in which various infectious agents are transmitted, the opinions of respected authorities, and common sense [A III].  Guidelines for the prevention of infection in solid organ transplant recipients should be tailored to the individual recipient by their physician with special consideration of the patient’s degree of immunosuppression and personal circumstances.

Prevention of Infections Transmitted by Direct Contact

Most organisms are acquired through either direct contact (carried on hands) or inhalation.  Frequent and thorough hand washing cannot be over-emphasized as a means of preventing infections that are transmitted by direct contact [AIII].  Hands should be washed with an antimicrobial soap and water [AIII].  Hygienic hand rubs are an acceptable alternative for maintaining clean hands. Gloves should be worn whenever handling heavily contaminated materials such as soil, moss or manure. Going barefooted should be avoided. Shoes, socks, long pants and long sleeved shirts should be worn while doing gardening, yardwork, farming, or being in parks or wooded areas. [CIII].  Administration of insect repellent and avoidance of outdoor exposures at dawn and dusk can help to prevent exposure to West Nile virus, during the summer and early fall in areas of possible transmission.

Hands should be washed [including after gloves are used]:

Prevention of Respiratory Infections

Microbes that cause respiratory infections are transmitted by either inhalation of aerosolized organisms or direct contact from contaminated hands to mucus membranes.  Thus, transmission of respiratory pathogens can be reduced by:

Water Safety/Exposure to Cryptosporidium

There are very few data delineating the risk for, and epidemiology of cryptosporidiosis among solid organ transplant recipients.  Albeit an uncommon infection in this population, Cryptosporidium can cause severe, chronic diarrheal disease in immunocompromised hosts, particularly those receiving corticosteroids. Therefore, it is prudent for solid organ transplant recipients to decrease their exposure to this pathogen.  The following precautions are suggested:

Food Safety

Many of the following recommendations have been made for the population at large.  These recommendations may be updated as new outbreaks are reported.  Clearly transplant recipients should:

Animal Contact and Pet Safety

Occupational risk
Transplant recipients who work with animals (veterinarians, pet store employees, farmers, slaughterhouse or laboratory workers) should, if possible, avoid working during periods of maximal immunosuppression [BIII].  When they return to work, they should minimize their exposure to potential pathogens by using proper precautions including hand washing, the use of gloves and masks as indicated.
Pet ownership
Health care providers must balance the psychological benefits of pet ownership with potential risks for transmission of infection when counseling solid organ transplant recipients on the safety of maintaining pets.

In general, transplant recipients should:
Cats can spread Toxoplasma, Cryptosporidium, Salmonella, Campylobacter (contaminated feces) and Bartonella (fleas and scratches).  Cat litter boxes should be changed daily (preferably not by transplant recipients), because it takes longer than 24 hours for toxoplasma oocysts to become infectious. 

Safe Sexual Practices.

Sexually active transplant recipients should:

Travel Safety

Travel to developing countries poses substantial risk to transplant recipients, particularly during periods of maximal immunosuppression [AIII].  Plans to travel should be discussed with the transplant recipient’s physician at least two months prior to the planned departure date.  All items discussed above are applicable for safe living during travel.  Updated travel advisories should be obtained from the CDC website www.cdc.gov .

While traveling in developing countries, the transplant recipient should avoid consuming:
To insure their safety transplant recipients should:
Whereas routine antimicrobial prophylaxis for diarrhea is not recommended, travelers should be given antibiotics to take with them and instructed on their use. Other issues related to travel safety include:

Citation

Strategies for safe living following solid organ transplantation. Am J Trasnplant 2004; 4(Suppl 10): 156-9.

Strength of Recommendations

Strength of Recommendations
A - Strongly recommended
B - Generally recommended
C - Optional
D - Generally not recommended
E - Never recommended

Quality of Evidence
I - Evidence from at least one well-executed RCT
II - Evidence from at least one well-designed clinical trial without randomization; cohort or case-controlled studies; analytic studies (preferably from more than one center); multiple time-series studies; or dramatic results from uncontrolled experiments
III - Evidence from opinions of respected authorities based on clinical experience, descriptive studies, or reports of expert committees.

References

1.    Schaffner A, Rubin, R.H., and Speich, R., editors. Immunocompromised Host Society Consensus Conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. Clin Infect Dis 2001;33:S1-S65.
2.    Rubin RH, and Young, L. S., editors. Clinical Approach to Infection in the Compromised Host. New York: Plenum; 2002.
3.    Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338(24):1741-51.
4.    Bowden RA, Ljungman, P, and Paya, C. V., editors. Transplant Infections, Second Edition. Philadelphia: Lippincott Williams and Wilkins; 2003.
5.    Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000;49(RR-10):1-125, CE1-7.
6.    Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002;51(RR-8):1-52.